RICHARD A. D’AUTILIO General Manager Consumer & Construction Division
March 23, 2012 Re:
EPA Chemical Action Plan
To:
All Bostik Hardwood Customers and Sales Representatives
In April 2011, the Environmental Protection Agency (“EPA”) released a Chemical Action Plan with respect to products containing a chemical substance known as “MDI” and the potential exposure to this substance by consumers and self-employed individuals. In February 2012, The American Chemistry Association hosted a meeting with EPA and various industry members in order to consider and discuss next actions to ensure consumer safety with the many products that contain MDI. Along with such other industry leaders as Bayer, BASF, and Dow, Bostik was an active participant in the February 2012 meeting, consistent with Bostik’s commitment to such matters and proactive approach to the health and safety of consumers and others who use its products. Bostik’s polyurethane wood flooring adhesive products contain extremely minimal quantities of residual MDI (0.1% to 1.0%), with very low volatility. Data Bostik has developed with an independent third party establish that these products do not result in any detectable exposure of MDI to applicators, others in the vicinity, or those present after application has been completed. Unfortunately, a competitor of Bostik, which appears just to have discovered EPA’s Plan nearly a year after its issuance, has begun an aggressive marketing campaign to attempt to exploit the Plan for commercial advantage. The competitor has issued a collection of marketing documents that misstate and mischaracterize the facts and expressly make clear the competitor’s commercial bias and motivation to ensure that “this opportunity should be worked and blitzed to its utmost.” Notably, this competitor, apparently focused on marketing, rather than safety, did not participate in the February 2012 meeting and therefore lacks even a fundamental understanding of the true facts regarding EPA’s thinking on the issues as communicated and discussed at the meeting. Nor does the competitor evince any understanding regarding the actual properties of Bostik’s products, which are demonstrably safe. If you have received and have concerns about the competitor’s strategic marketing set of documents, we would be happy to answer any questions you may have. We would specifically like to bring the following to your attention: